Contact Us | Useful Links | FAQs | Feedback | Sitemap |
 
   
 
An integrated strategy for the advancement of the Drug Holding Company :: The Ministry of Public Business Sector announces :: Holdipharma: Providing medical supplies to the hospitals of the Ministry of Health :: The National Bank and HoldiPharma sign a cooperation protocol :: Medicines Holding: We are not a party to the crisis of high alcohol prices ... ::
 
 
Company Details
Company Name   Website
kahira   www.kahira-pharma.com
     
Description

Kahira Co. for Pharmaceutical and Chemical Industries was established in 1962 after the integration of three small facilities working in the production of pharmaceutical products (Alpha – Douche – C-pharm) then Beida was joined to this entity later on, they all constituted a concise and limited entity upon that time.

Since 1962, the government decided to expand this entity to be a well-established large scale manufacturing facility and to conclude other production lines for almost all the pharmaceutical dosage forms, to fulfill the extra production demands needed for local market and for most of the Arab countries.

Kahira pharmaceutical company was distinguished as the first one between drug companies in the production of soft gelatin capsules, and the production of Syrups, Lotions, sterile and non-sterile drops, dry powders and granules, ointments and pastes.

The company has a unique sterile dedicated area for the production of cephalosporins that was established by the aid of American expertise and in accordance to the latest international guidelines.

------------------

Company product catalog

Download

Company product profile

Download

Board Members

Dr/ yaser ahmed  farghly                               Managing Director 

Dr/ Adel taha abd elwahab                               Chairman of the Board

Mrs/ Dina asmail elkialy                                     Executive Member

Mr/ Mohamed abd Moaty metwaly                          Member

Mr/ Salem mohamed salem                                    Member

 

Audit Committee:

Dr/ Adel taha abd elwahab                                  Chairman

Mrs/ Dina asmail elkialy                                         Member

Mr/ Salem mohamed salem                                      Member

Mrs/ Hanan  Issa                                                  Member

 

 

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator 2018-2019 2019-2020 2020-2021
Net Operating Revenue

962945

1010341

1062046
Interest Expenses 0 0 0
Net Income 85170 109140 124305
Net Equity 603664 653756 703733
Working Capital 453935 515710 557290
Total Investment 608934 659780 1068473
Salaries 202241 192540 185990
Number of workers 2492 2386 2280

   
Image Gallery
 
     
Related Links
Affiliates
   
Joint Venture
   
   
   
   
 
 
     
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |